Skip to search formSkip to main contentSkip to account menu

Coagulants

Known as: coagulant 
Agents that cause clotting.
National Institutes of Health

Related topics

Related topics

38 relations

Narrower (7)

ANTI-INHIBITOR COAGULANT COMPLEXCoagulaseFactor VIIIKininogenase
Blood Coagulation FactorBlood coagulationFactor IXaFactor V

Broader (1)

Hematologic Agents

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2006
Review
2006
Laboratory identification of von Willebrand disease: technical and scientific perspectives.
The correct diagnosis and classification of von Willebrand disease (von Willebrand disorder; vWD) is crucial because the… 
Review
2006
Review
2006
Clay and oxide destabilization induced by mixed alum/macromolecular flocculation aids.
Highly Cited
1998
Highly Cited
1998
A rapid procedure for the isolation of the Lys-49 myotoxin II from Bothrops moojeni (caissaca) venom: biochemical characterization, crystallization, myotoxic and edematogenic activity.
Highly Cited
1994
Highly Cited
1994
Isolation and characterization of thrombin-activated human factor VIII.
Highly Cited
1993
Highly Cited
1993
Analysis of the functions of the first epidermal growth factor-like domain of factor X.
Highly Cited
1990
Highly Cited
1990
Characterization of the functional defect in factor IX Alabama. Evidence for a conformational change due to high affinity calcium binding in the first epidermal growth factor domain.
Highly Cited
1987
Highly Cited
1987
Characterization of recombinant human factor VIII.
Highly Cited
1973
Highly Cited
1973
Titration of activated bovine Factor X.
Highly Cited
1968
Highly Cited
1968
Anticoagulant therapy with a purified fraction of Malayan pit viper venom.
Highly Cited
1968
Highly Cited
1968
The paradox in therapeutic defibrination.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)